Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R01MH0933 21-01A1 | Other Grant/Funding Number | National Institite of Mental Health |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Mental Health (NIMH) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Bipolar disorder (BD) is a serious and chronic mental illness that is associated with substantial impairment in quality of life and functional outcomes, high rates of suicide, and high financial costs. In spite of a proliferation of treatments for BD, nearly half of individuals with BD do not benefit from pharmacotherapy because of sub-optimal medication treatment adherence. Non-adherence with BD medication treatment dramatically worsens outcomes. Reasons for non-adherence among individuals with BD are multi-dimensional, and it has been suggested that adherence enhancement might work best if the intervention specifically addresses factors that are important and modifiable for a specific individual. In spite of the enormity of the problem, the literature on interventions to improve treatment adherence is surprisingly limited. There is an urgent need for interventions to enhance treatment adherence among BD patients that: 1) are at high risk for future treatment non-adherence; 2) may not have access to or interest in long-term, high-intensity, and specialized care; and 3) are flexible and patient-focused taking into account reasons for non-adherence for a specific individual.
The proposed study is a first-ever RCT focused specifically on BD treatment adherence enhancement, and will test whether a customized adherence enhancement (CAE) psychosocial intervention improves adherence and mental health outcomes compared to broadly-directed, non-individualized education (EDU). The proposed project has the potential to greatly advance the care of BD patients who are at greatest risk for poor health outcomes, with findings expected to be generalizable across a variety of treatment settings.
Hypothesis 1: CAE will be associated with greater improvement in treatment adherence compared to broadly-directed, non-individualized BD education (EDU).
Hypothesis 2: CAE will be associated with improved BD symptoms compared to EDU.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Customized Adherence Enhancement (CAE) | Experimental | This arm will receive the CAE intervention. |
|
| broad non-individualized education (EDU) | Active Comparator | This arm will receive the EDU intervention. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Customized Adherence Enhancement (CAE) | Behavioral | CAE consists of the application of a series of up to four psychosocial treatment modules based upon a baseline evaluation of adherence vulnerabilities/needs. The standardized modules (Psychoeducation, Modified Motivational Enhancement Therapy, Communication with Providers, Medication Routines), are assigned based upon pre-established criteria designed to fit the needs of the patient. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in the Tablet Routine Questionaire (TRQ) "past month" item at 24 weeks | The TRQ "past month" item is a subject report of the percentage of prescribed medications not taken within the past month. | Baseline and 24 weeks |
| Change from baseline in the Tablet Routine Questionaire (TRQ) "past week" item at 24 weeks | The TRQ "past week" item is a subject report of the percentage of prescribed medications not taken within the past week. | Baseline and 24 weeks |
| Change from baseline in treatment adherence as measured by special pill cap counter at 24 weeks | A special pill cap will record the time/date of bottle opening. The cap will be used for the medication that the patient takes the most frequently (in the case of multiple BD medications taken at same frequency, the medication that was started most recently will be selected). A dose will be counted as "taken" if the bottle is opened within two hours of the prescribed time. A percent of doses taken (treatment adherence) will be calculated by dividing the number of times the bottle is opened by the number of times it should have been opened as per the prescription. | Baseline and 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in Brief Psychiatry Symptom Scale (BPRS) at 24 weeks | baseline and 24 weeks | |
| Change from baseline in Montgomery Asberg Depression Rating Scale (MADRS) at 24 weeks | baseline and 24 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Martha Sajatovic, M.D. | University Hospitals Cleveland Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 29351117 | Derived | Aftab A, Levin J, Aebi M, Bhat C, Sajatovic M. Associations of Comorbid Anxiety With Medication Adherence and Psychiatric Symptomatology in a Population of Nonadherent Bipolar Disorder Subjects. J Nerv Ment Dis. 2018 Apr;206(4):258-262. doi: 10.1097/NMD.0000000000000788. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010349 | Patient Compliance |
| D001714 | Bipolar Disorder |
| ID | Term |
|---|---|
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| broadly-directed, non-individualized education (EDU) | Behavioral | EDU will consist of 4 core in-person sessions using the patient work-book from the NIMH funded study, Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD), and following the general educational format of the Collaborative Care "control" intervention in the STEP study. EDU addresses BD treatment broadly, including diagnosis and management, and the sessions will review the materials and allow time for questions as needed. |
|
| Change from baseline in Young Mania Rating Scale (YMRS) at 24 weeks | baseline and 24 weeks |
| Change from baseline in Clinical Global Impression, Bipolar Version (CGI-BP) at 24 weeks | baseline and 24 weeks |
| Change from baseline in Global Assessment of Functioning (GAF) at 24 weeks | baseline and 24 weeks |
| Change from baseline in General Self Efficacy Scale at 24 weeks | baseline and 24 weeks |
| Change from baseline in the Drug and Alcohol portion of the Addiction Severity Index (ASI) at 24 weeks | baseline and 24 weeks |
| Change from baseline in Treatment alliance (Trust in Providers scale) at 24 weeks | baseline and 24 weeks |
| Change from baseline in Stigma for Mental Illness Scale at 24 weeks | baseline and 24 weeks |
| Change from baseline in Drug Attitudes Inventory (DAI) at 24 weeks | baseline and 24 weeks |
| D000068105 | Bipolar and Related Disorders |
| D019964 | Mood Disorders |
| D001523 | Mental Disorders |